NCT07388394 Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75
| NCT ID | NCT07388394 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Centre Hospitalier Universitaire de Nice |
| Condition | Virus-HIV |
| Study Type | INTERVENTIONAL |
| Enrollment | 136 participants |
| Start Date | 2026-01-28 |
| Primary Completion | 2027-08-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 136 participants in total. It began in 2026-01-28 with a primary completion date of 2027-08-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Since the advent of antiretroviral treatments, the life expectancy of people living with HIV (PLHIV) has increased significantly. In France, more than 30% of PLHIV are now over 50 years old. This population is exposed to high multimorbidity, leading to frequent polypharmacy, defined as the regular use of at least five medications. Polypharmacy also has a qualitative dimension, including potentially inappropriate prescriptions. It increases the risk of adverse effects and drug interactions and impairs quality of life. A coordinated geriatric approach is therefore essential to optimize care. Healthy aging, promoted by the WHO, aims to improve the lives of older people. In this context, a study will be conducted at the Nice University Hospital among PLHIV aged 75 and over. It will collect quantitative data, the results of which will enable us to consider, if necessary, adapting the care pathways of these patients whose needs are complex.
Eligibility Criteria
Inclusion Criteria: * HIV-positive * Aged 75 or over * Affiliated with the social security system * Having expressed no objection to participating in the study Exclusion Criteria: * Refusal to participate * Known severe cognitive impairment preventing the interview from being conducted * Patient under guardianship or conservatorship
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07388394 clinical trial?
This trial is open to participants of all sexes, aged 75 Years or older, studying Virus-HIV. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07388394 currently recruiting?
Yes, NCT07388394 is actively recruiting participants. Contact the research team at blanckerman.l@chu-nice.fr for enrollment information.
Where is the NCT07388394 trial being conducted?
This trial is being conducted at Nice, France.
Who is sponsoring the NCT07388394 clinical trial?
NCT07388394 is sponsored by Centre Hospitalier Universitaire de Nice. The trial plans to enroll 136 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.